 | Articles: General Pharma
|
Teva Announces Launch of Generic Protonix(R) Tablets, 20 mg and 40 mg
Corporate News Releases, 12/26/07
Pfizer Receives Approvable Letter from FDA for Dalbavancin
Corporate News Releases, 12/26/07
Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Corporate News Releases, 12/26/07
Power Medical Interventions, Inc. Receives FDA 510(k) Marketing Clearance for iDrive Intelligent Surgical Instruments
Corporate News Releases, 12/26/07
CSL could benefit from Glaxo delay
PharmiWeb, 12/26/07
Drug firms, salesmen on collision course
PharmiWeb, 12/26/07
Improved Optimized Protocols for COS-7 and U-937
Amaxa Biosystems, 12/26/07
Elan and Wyeth Dose First Patient in North America in Phase 3 Program for Bapineuzumab (AAB-001) in Alzheimers Disease
Elan, 12/26/07
MediGene Enlists Dr. Frank Mathias, General Manager of Amgen Germany, as Board Member for Marketing and Business Development
MediGene, 12/26/07
NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
NPS Pharmaceuticals, 12/26/07
|
 Receive daily email updates on General Pharma
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
